The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making

被引：8

作者：

Lerro, Catherine C. ^{[1
]}

Bradley, Marie C. ^{[2
]}

Forshee, Richard A. ^{[3
]}

Rivera, Donna R. ^{[1
]}

机构：

[1] US FDA, Oncol Ctr Excellence, Off Commissioner, Silver Spring, MD USA

[2] US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD 20993 USA

[3] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA

来源：

JCO CLINICAL CANCER INFORMATICS | 2024年 / 8卷

关键词：

D O I：

10.1200/CCI.23.00261

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 16 条

[1] Guidelines for good pharmacoepidemiology practice (GPP) [J].

Andrews, Elizabeth B. ;

Arellano, Felix M. ;

Avorn, Jerry ;

Bortnichak, Edward A. ;

Chen, Robert ;

Dai, Wanju S. ;

de Abajo, Francisco J. ;

Dieck, Gretchen S. ;

de Vries, Corinne ;

Edlavitch, Stanley ;

Freiman, Joel ;

Hallas, Jesper ;

Jones, Judith K. ;

Koo, Linda ;

Kaufman, David W. ;

Kurz, Xavier ;

Lanes, Stephan ;

Mitchell, Allen A. ;

Moride, Yola ;

Nelson, Robert C. ;

Neutel, Ineke ;

Park, Byung-Joo ;

Perez-Gutthann, Susana ;

Reynolds, Robert ;

Sacks, Susan ;

Santanello, Nancy ;

Stang, Paul ;

Stergachis, Andrew ;

Strom, Brian L. ;

Stuermer, Til ;

Toh, Darren ;

Trontell, Anne ;

Walker, Alexander M. ;

Waller, Patrick ;

Watson, Douglas J. ;

West, Suzanne ;

Wilcock, Karen ;

Wise, Robert P. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (01) :2-10

[2]

[Anonymous], Cancer Moonshot

[3]

[Anonymous], 2018, Framework for FDA's Real-World Evidence Program

[4]

[Anonymous], 2023, Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products

[5]

[Anonymous], 2021, Data Standards for Drug and Biological Product Submissions Containing Real-World Data, Draft Guidance for Industry

[6]

[Anonymous], 2023, Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products

[7]

[Anonymous], 2022, PDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2023 through 2027

[8] Exploring the ethical and regulatory issues in pragmatic clinical trials [J].

Califf, Robert M. ;

Sugarman, Jeremy .

CLINICAL TRIALS, 2015, 12 (05) :436-441

[9] Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions [J].

Castellanos, Emily H. ;

Wittmershaus, Brett K. ;

Chandwani, Sheenu .

JCO CLINICAL CANCER INFORMATICS, 2024, 8

[10] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

← 1 2 →